Graeme C. Clark

1.3k total citations
32 papers, 981 citations indexed

About

Graeme C. Clark is a scholar working on Molecular Biology, Infectious Diseases and Immunology. According to data from OpenAlex, Graeme C. Clark has authored 32 papers receiving a total of 981 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Molecular Biology, 13 papers in Infectious Diseases and 13 papers in Immunology. Recurrent topics in Graeme C. Clark's work include Bacillus and Francisella bacterial research (10 papers), Clostridium difficile and Clostridium perfringens research (8 papers) and Toxin Mechanisms and Immunotoxins (8 papers). Graeme C. Clark is often cited by papers focused on Bacillus and Francisella bacterial research (10 papers), Clostridium difficile and Clostridium perfringens research (8 papers) and Toxin Mechanisms and Immunotoxins (8 papers). Graeme C. Clark collaborates with scholars based in United Kingdom, Costa Rica and Sweden. Graeme C. Clark's co-authors include Petra C. F. Oyston, Riccardo V. D’Elia, Roman A. Lukaszewski, Kate Harrison, Richard W. Titball, Marc A. Fox, Sarah‐Jane Richards, Simon M. Cutting, Huynh A. Hong and Tran Huy Hoang and has published in prestigious journals such as Journal of Biological Chemistry, Nature Communications and Journal of Molecular Biology.

In The Last Decade

Graeme C. Clark

32 papers receiving 962 citations

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
Graeme C. Clark 406 298 235 184 122 32 981
Anna Gołda 291 0.7× 408 1.4× 150 0.6× 116 0.6× 116 1.0× 26 797
Mariette Barbier 441 1.1× 178 0.6× 106 0.5× 261 1.4× 246 2.0× 59 1.1k
Kaixiang Zhu 518 1.3× 273 0.9× 231 1.0× 61 0.3× 101 0.8× 35 1.1k
Dominique Granato 704 1.7× 125 0.4× 284 1.2× 111 0.6× 75 0.6× 20 1.5k
Ken‐ichi Amano 233 0.6× 178 0.6× 386 1.6× 200 1.1× 303 2.5× 41 1.1k
Xiaotian Huang 496 1.2× 292 1.0× 209 0.9× 243 1.3× 396 3.2× 74 1.3k
Bart W. Bardoel 537 1.3× 244 0.8× 419 1.8× 175 1.0× 143 1.2× 33 1.3k
Isabelle Hautefort 716 1.8× 345 1.2× 204 0.9× 165 0.9× 155 1.3× 33 1.7k
Régis Stentz 802 2.0× 200 0.7× 104 0.4× 442 2.4× 165 1.4× 30 1.2k
Shisong Fang 229 0.6× 352 1.2× 103 0.4× 64 0.3× 244 2.0× 65 866

Countries citing papers authored by Graeme C. Clark

Since Specialization
Citations

This map shows the geographic impact of Graeme C. Clark's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Graeme C. Clark with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Graeme C. Clark more than expected).

Fields of papers citing papers by Graeme C. Clark

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Graeme C. Clark. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Graeme C. Clark. The network helps show where Graeme C. Clark may publish in the future.

Co-authorship network of co-authors of Graeme C. Clark

This figure shows the co-authorship network connecting the top 25 collaborators of Graeme C. Clark. A scholar is included among the top collaborators of Graeme C. Clark based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Graeme C. Clark. Graeme C. Clark is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Laidlaw, Stephen M., David Ulaeto, Graeme C. Clark, et al.. (2025). Detection of mpox and other orthopoxviruses using a lateral flow device as a point-of-care diagnostic. Microbiology Spectrum. 13(4). e0245624–e0245624. 2 indexed citations
2.
Clark, Graeme C., Stuart D. Armstrong, Angela Essex-Lopresti, et al.. (2022). From “crisis to recovery”: A complete insight into the mechanisms of chlorine injury in the lung. Life Sciences. 312. 121252–121252. 3 indexed citations
3.
Houston, Stephanie, Suélen Andreia Rossi, E. Diane Williamson, et al.. (2019). CD200R deletion promotes a neutrophil niche for Francisella tularensis and increases infectious burden and mortality. Nature Communications. 10(1). 2121–2121. 23 indexed citations
4.
Clark, Graeme C., Nicholas R. Casewell, Christopher T. Elliott, et al.. (2019). Friends or Foes? Emerging Impacts of Biological Toxins. Trends in Biochemical Sciences. 44(4). 365–379. 45 indexed citations
5.
D’Elia, Riccardo V., et al.. (2017). Mitogen-activated protein kinases (MAPKs) are modulated during in vitro and in vivo infection with the intracellular bacterium Burkholderia pseudomallei. European Journal of Clinical Microbiology & Infectious Diseases. 36(11). 2147–2154. 4 indexed citations
6.
Griffiths, Gareth, et al.. (2017). Production, Characterisation and Testing of an Ovine Antitoxin against Ricin; Efficacy, Potency and Mechanisms of Action. Toxins. 9(10). 329–329. 8 indexed citations
7.
D’Elia, Riccardo V., et al.. (2016). Mitogen-activated protein kinases (MAPKs) are modulated during Francisella tularensis infection, but inhibition of extracellular-signal-regulated kinases (ERKs) is of limited therapeutic benefit. European Journal of Clinical Microbiology & Infectious Diseases. 35(12). 2015–2024. 9 indexed citations
8.
Laws, Thomas R., Graeme C. Clark, & Riccardo V. D’Elia. (2015). Immune profiling of the progression of a BALB/c mouse aerosol infection by Burkholderia pseudomallei and the therapeutic implications of targeting HMGB1. International Journal of Infectious Diseases. 40. 1–8. 11 indexed citations
9.
David, Jonathan, Rachel E. Bell, & Graeme C. Clark. (2015). Mechanisms of Disease: Host-Pathogen Interactions between Burkholderia Species and Lung Epithelial Cells. Frontiers in Cellular and Infection Microbiology. 5. 80–80. 24 indexed citations
10.
D’Elia, Riccardo V., Thomas R. Laws, Alejandro Núñez, Christopher E. Taylor, & Graeme C. Clark. (2014). Delayed presence of alternatively activated macrophages during a Francisella tularensis infection. Microbial Pathogenesis. 78. 37–42. 3 indexed citations
11.
D’Elia, Riccardo V., Thomas R. Laws, Alejandro Núñez, & Graeme C. Clark. (2014). “FoxP3 Hunting” during Infection with Francisella Tularensis. International Journal of Immunopathology and Pharmacology. 27(4). 585–595. 1 indexed citations
12.
Flores-Dı́az, Marietta, et al.. (2012). Reactive Oxygen Species and the MEK/ERK Pathway Are Involved in the Toxicity of Clostridium perfringens  -Toxin, a Prototype Bacterial Phospholipase C. The Journal of Infectious Diseases. 206(8). 1218–1226. 17 indexed citations
13.
Morris, Christopher J., Konrad Beck, Marc A. Fox, et al.. (2012). Pegylation of Antimicrobial Peptides Maintains the Active Peptide Conformation, Model Membrane Interactions, and Antimicrobial Activity while Improving Lung Tissue Biocompatibility following Airway Delivery. Antimicrobial Agents and Chemotherapy. 56(6). 3298–3308. 74 indexed citations
14.
Vachieri, S.G., Graeme C. Clark, Alberto Alape‐Girón, et al.. (2010). Comparison of a nontoxic variant ofClostridium perfringensα-toxin with the toxic wild-type strain. Acta Crystallographica Section D Biological Crystallography. 66(10). 1067–1074. 5 indexed citations
15.
Oyston, Petra C. F., Marc A. Fox, Sarah‐Jane Richards, & Graeme C. Clark. (2009). Novel peptide therapeutics for treatment of infections. Journal of Medical Microbiology. 58(8). 977–987. 116 indexed citations
16.
Clark, Graeme C., et al.. (2007). Analysis of protection afforded by a Clostridium perfringens α-toxoid against heterologous clostridial phospholipases C. Microbial Pathogenesis. 43(4). 161–165. 18 indexed citations
17.
Clark, Graeme C., Ajit K. Basak, & Richard W. Titball. (2007). The Rational Design of Bacterial Toxin Inhibitors. Current Computer - Aided Drug Design. 3(1). 1–12. 3 indexed citations
18.
Flores-Dı́az, Marietta, Alberto Alape‐Girón, Graeme C. Clark, et al.. (2005). A Cellular Deficiency of Gangliosides Causes Hypersensitivity to Clostridium perfringens Phospholipase C. Journal of Biological Chemistry. 280(29). 26680–26689. 48 indexed citations
19.
Clark, Graeme C., David C. Briggs, Tadahiro Karasawa, et al.. (2003). Clostridium absonum α-Toxin: New Insights into Clostridial Phospholipase C Substrate Binding and Specificity. Journal of Molecular Biology. 333(4). 759–769. 22 indexed citations
20.
Karlyshev, Andrey V., Petra C. F. Oyston, Katrina Williams, et al.. (2001). Application of High-Density Array-Based Signature-Tagged Mutagenesis To Discover Novel Yersinia Virulence-Associated Genes. Infection and Immunity. 69(12). 7810–7819. 72 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Anna Gołda Breakdown of academic impact, for papers by Mariette Barbier Breakdown of academic impact, for papers by Kaixiang Zhu Breakdown of academic impact, for papers by Dominique Granato Breakdown of academic impact, for papers by Ken‐ichi Amano Breakdown of academic impact, for papers by Xiaotian Huang Breakdown of academic impact, for papers by Bart W. Bardoel Breakdown of academic impact, for papers by Isabelle Hautefort Breakdown of academic impact, for papers by Régis Stentz Breakdown of academic impact, for papers by Shisong Fang
Rankless by CCL
2026